//
home

Latest Post

New Hepatitis C Combo On the Way

Another once-daily pill is on-track for approval by the U.S. Food and Drug Administration (FDA) for the treatment of hepatitis C, adding to the growing number of treatment options for this life-threatening disease. This time, it’s a combination of Sovaldi® (sofosbuvir) with a new NS5A inhibitor called velpatasvir from Gilead Sciences. The sofosbuvir-velpatasvir combination is … Continue reading

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 162 other followers

Twitter Updates

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 162 other followers

Like Us On Facebook!

February 2016
M T W T F S S
« Jan    
1234567
891011121314
15161718192021
22232425262728
29  

Archives

Follow

Get every new post delivered to your Inbox.

Join 162 other followers